Volume 127, Issue 4, Pages 1038-1043 (October 2004) Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: Results of a randomized double-blind trial Francis K.L. Chan, Lawrence C.T. Hung, Bing Y. Suen, Vincent W.S. Wong, Aric J. Hui, Justin C.Y. Wu, Wai K. Leung, Yuk T. Lee, Ka F. To, S.C. Sydney Chung Gastroenterology Volume 127, Issue 4, Pages 1038-1043 (October 2004) DOI: 10.1053/j.gastro.2004.07.010 Copyright © 2004 American Gastroenterological Association Terms and Conditions
Figure 1 Kaplan-Meier estimates of the cumulative probabilities of recurrent ulcer in the celecoxib group and the omeprazole plus diclofenac group. There was no significant difference between the 2 treatment groups. Gastroenterology 2004 127, 1038-1043DOI: (10.1053/j.gastro.2004.07.010) Copyright © 2004 American Gastroenterological Association Terms and Conditions